Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1670 of 6351
-
New BiTE-EV therapy tested for Tough-to-Treat leukemia
Disease control Recruiting nowThe goal of this clinical trial is to learn if BiTE-EV works to treat relapsed/refractory acute B-cell leukemia in adults. It will also learn about the safety of BiTE-EV. The main questions it aims to answer are: Can BiTE-EV effectively treat relapsed/refractory acute B-cell lym…
Early phase 1 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Gene-edited cell therapy for beta-thalassemia: long-term safety check begins
Disease control By invitation onlyThis is a study to evaluate the long-term safety and efficacy of CS-101 in participants who received CS-101 in study CS -101-06 (NCT06024876),No investigational drug product will be administered in the study.
Sponsor: CorrectSequence Therapeutics Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Can a dissolvable bone wax curb bleeding during spine fusion?
Disease control By invitation onlyIn spine surgery, it is important to try to minimize bleeding. In particular, spine surgery often involves inserting hardware into bone, and/or removing bone in the spine. Because the bone in the spine contains blood vessels, there can often be bleeding from the bone itself that …
Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Could a lung wash replace needle biopsies for cancer gene tests?
Diagnosis Recruiting nowPatients with advanced non-small cell lung cancer (NSCLC) usually undergo biopsies to obtain cytological material on which to perform Next Generation Sequencing (NGS) analysis, with the aim of identifying driver gene mutations that may be targeted by specific therapies. With the …
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Diagnosis
Last updated Jun 27, 2026 07:51 UTC
-
New drug RBS2418 aims to rev up immune system against tough colorectal cancer
Disease control Recruiting nowRBS2418 is a specific immune modulator that works through the inhibition of ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) and is designed to lead to anti-tumor immunity by protecting endogenous 2'-3'-cyclic guanosine monophosphate-adenosine monophosphate (cGAMP) from…
Phase 2 • Sponsor: Riboscience, LLC. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New drug shows promise in keeping blood cancers at bay after transplant
Disease control Recruiting nowThis phase I trial tests the safety, side effects, and effectiveness of olutasidenib in preventing the return of disease (relapse) in patients who have undergone donor (allogeneic) hematopoietic cell transplant for acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or …
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New pill aims to slow lung scarring in IPF patients
Disease control CompletedThis study is open to adults with idiopathic pulmonary fibrosis who are at least 40 years old. The main objective is to evaluate of the efficacy and the secondary objective is to evaluate the safety and pharmacokinetic.
Phase 2 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Can a smarter ventilator ease breathing for asthma and COPD patients?
Disease control Recruiting nowThe goal of this physiological pilot study with a randomized crossover design is to study the effect of Flow-controlled ventilation (FCV) on the minute volume compared to Volume-controlled ventilation (VCV) in intubated patients with an exacerbation of their asthma or COPD. Our …
Sponsor: Erasmus Medical Center • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Real-Time MRI scans during brain surgery could boost tumor removal
Disease control Recruiting nowThe study aims to improve the surgical treatment of brain metastases through the use of advanced imaging techniques. The investigators are examining how intraoperative MRI (iMRI) can aid surgeons in precisely locating and removing tumors, with the potential to enhance surgical ou…
Sponsor: Technical University of Munich • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New hope for liver disease: drug shows promise in reducing damage
Disease control OngoingThe purpose of this study is to find out about the safety and how well the study intervention (elafibranor) works in participants with PBC. The participants in this study will have confirmed PBC with inadequate response or intolerance to UDCA, which is a medication used in the ma…
Phase 3 • Sponsor: Ipsen • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Refugee stress study: extra booster sessions may ease trauma and boost integration
Symptom relief Recruiting nowRefugees and asylum seekers (RAS) face numerous stressors and adversities which put them at risk for developing mental health problems. However, access to adequate mental health care in host countries is limited. To address this problem, the World Health Organization (WHO) introd…
Sponsor: University of Zurich • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Can a simple feeding protocol help the tiniest babies thrive?
Disease control Recruiting nowThe goal of the LIFT-UP randomized controlled trial is to evaluate the efficacy of feeding routinely and fortified human milk using a standardized clinical protocol to very low birthweight (VLBW) or very preterm (VPT) infants in the NICU compared to not feeding routinely fortifie…
Sponsor: Harvard School of Public Health (HSPH) • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New hope for Hard-to-Treat lymphoma? early trial of ABBV-291 begins
Disease control OngoingNon-Hodgkin's lymphoma (NHL) is a cancer that arises from the transformation of normal B and T lymphocytes (white blood cells). The purpose of this study is to assess the safety, tolerability, pharmacokinetics, and preliminary efficacy of ABBV-291 in adult participants in relapse…
Phase 1 • Sponsor: AbbVie • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Heat therapy: a new hope for long COVID sufferers?
Symptom relief Recruiting nowPost-acute sequelae of SARS-CoV-2 infection (PASC) is becoming a major risk factor for chronic diseases, with older adults and those with underlying health conditions at risk of developing persistent mobility limitations and disabilities. Although exercise intervention is a commo…
Sponsor: University of Nebraska • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
Can targeted therapy ease the mental health toll of stigma in LGBTQ+ people?
Symptom relief Recruiting nowLesbian, gay, bisexual, transgender, and queer+ (LGBTQ+) individuals experience a breadth of mental health disparities. Reducing these disparities is an area of key psychological research. Minority stress is theorized to be an underlying source of the disparities (Meyer, 2003). M…
Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
Gut bacteria transplant could tame Crohn's inflammation
Disease control Recruiting nowCrohn's disease (CD) develops because of a disruption of homeostasis between the gut microbiota and the host immune system resulting in excessive inflammation in the intestinal tract. Current drug therapies for CD are directed at the immune system. The emergence of fecal microbio…
Phase 2 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Could a simple pill replace the IV drip for ER infections?
Disease control Recruiting nowPatients admitted to the hospital with acute infections are often treated with intravenous (IV) antibiotics. Around 70% of these infections fall into three categories: respiratory tract infections, urinary tract infections, and cellulitis. A Danish study found that 76% of patient…
Sponsor: University of Southern Denmark • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Zapping the brain while in VR: a new hope for social skills?
Symptom relief Recruiting nowThe cerebellum is increasingly recognized for its crucial role in high-level cognitive processes, particularly in the domain of social cognition and action prediction. Disruptions in cerebellar circuits can lead to significant impairments in anticipating others' intentions and be…
Sponsor: I.R.C.C.S. Fondazione Santa Lucia • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Can a desk workout plus pilates beat the office aches?
Symptom relief CompletedThis study evaluated whether adding Pilates exercises to a desk-based exercise program provides greater benefits for female office workers than desk-based exercises alone or no exercise intervention. The study included 42 female office workers who were randomly assigned to three …
Sponsor: Muharrem Gökhan Beydağı • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Could testosterone therapy be safe for men with prostate cancer? new trial aims to find out
Disease control Recruiting nowThis phase IV trial studies the effects of testosterone replacement therapy (TRT) on treatment outcomes in hypogonadal men with prostate cancer that has not spread to other parts of the body (localized) and who are on active surveillance (AS). AS in prostate cancer involves close…
Phase 4 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC